This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

UBS faces appeal at top Swiss court over Credit Suisse drug-money case

By Martin Coyle ( May 9, 2025, 13:24 GMT | Insight) -- Swiss banking giant UBS faces an appeal over a legacy accusation that rival Credit Suisse, which it took over two years ago, failed to prevent an employee from laundering the proceeds of Bulgarian drug money through the bank. Credit Suisse was convicted for money laundering in 2022, but cleared on appeal last year. Swiss prosecutors said today they have appealed the case up to the country's Supreme Court. UBS faces an appeal by Swiss prosecutors over a legacy accusation that Credit Suisse failed to prevent an employee from laundering the proceeds of Bulgarian drug money through the bank....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login